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Fig. 1. Fold change expression levels of inﬂammatory mediators and
adipokines measured infrapatellar fat pad after idealized ACL recon-
struction in a sheep knee. Levels are normalized to 18S rRNA. Levels are
normalized to 18S rRNA.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S295Leukocyte-rich Platelet rich plasma (L-PRP). Platelets and leukocytes
counts were performed on samples of blood, PRGF and L-PRP with a
hematology analyzer. Morphological analysis of PRGF and L-PRP scaf-
folds was performed with scanning electron microscopy (SEM).
Mechanical properties of the scaffolds were determined by a tensile
test. PRGF and L-PRP scaffolds were incubated in the absence (non-
inﬂammatory conditions) or presence of inﬂammatory condition. The
conditioned media released by the different scaffolds was collected and
the concentration of several growths factors and pro-inﬂammatory
cytokines was determined by enzyme-linked immunosorbent assay
(ELISA).
Results: Inclusion of the white blood cells in the PRP increased the
presence of leukocytes from 0.2 to 19.3. The biological outcomes of the L-
PRP under inﬂammatory conditions were dramatically altered compared
with the outcomes showed by the PRGF. In fact, the structure of ﬁbrin
network was signiﬁcantly modiﬁed due to the leukocytes and the pres-
ence of MMP-1 within the scaffolds increased from 2 to 79 ng/mL. As a
consequence the leukocyte containing ﬁbrin membranes were more
fragile, reducing both their elongation capacity and the time until
membrane rupture in more than 28% compared to PRGF scaffolds. The
release of pro-inﬂammatory cytokines from scaffolds was signiﬁcantly
increased when leukocytes were included in the PRP and an inﬂamma-
tory conditionwas evaluated. The amount of TNF-alpha, IL-6, IL-1 and IL-
8 released from the L-PRP ﬁbrin scaffolds was 31, 248, 151 and 381-fold
higher than from PRGF scaffolds. The inﬂammatory response of ﬁbroblast
was signiﬁcantly higher to L-PRP condicioned cultures than to PRGF ones.
Conclusions: Compared with PRGF, L-PRP induces signiﬁcantly higher
pro-inﬂammatory conditions. The inclusion of leukocytes alters ﬁbrin
network, reduces its biomechanical properties and increases the pres-
ence of pro-inﬂammatory cytokines such as TNF-alpha, IL-6, IL-1 and IL-
8, which deeply inﬂuences the cellular inﬂammatory response.
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MOLECULAR RESPONSES OF THE INFRAPATELLAR FAT PAD MAY
CONTRIBUTE TO PATHOLOGICAL CHANGES IN THE KNEE JOINT
FOLLOWING IDEALIZED ANTERIOR CRUCIATE LIGAMENT SURGERY.
N.M. Solbak, Y. Achari, M. Chung, B.J. Heard, N.G. Shrive, C.B. Frank,
D.A. Hart. The Univ. of Calgary, Calgary, AB, Canada
Purpose: Severe injuries to the anterior cruciate ligament (ACL) require
surgical reconstruction to restore mechanical stability in the knee joint.
In spite of successful surgical reconstruction, in some cases the cartilage
of the knee joint exhibits signs of degeneration analogous to symptoms
related to osteoarthritis (OA). The causes leading to OA even after suc-
cessful reconstruction remain to be deﬁned. We developed a surgical
model of an “idealized reconstruction of ACL” and hypothesized that
immediate anatomical reconstruction of ACL will not lead to degener-
ation of the knee joint components. However, previous examination of
synovium, cartilage and the ACL exhibited elevated molecular respon-
ses for inﬂammatory and degradative biomarkers early after the sur-
gery, which subsided by 20 weeks. As the different components of the
knee joint function as an integrated coordinated system, in the present
study we examined the molecular responses in the infrapatellar fat pad
(IPFP). The IPFP is present in the anterior compartment of the knee joint
in close proximity to the synovial layers and cartilage surfaces. This
suggests that the IPFP may be able to inﬂuence the catabolic and
inﬂammatory processes in different components of the knee joint.
Previous reports have observed pathological changes in this tissue
either following arthroscopic procedures or secondary to knee joint
insults such as patellar dislocation and tendonitis. This study was based
on the hypothesis that following ACL-R, molecular changes will be
initiated in the IPFP that will be sustained over time, thus acting as a
molecular repository for ﬁbrotic processes in the joint.
Methods: In this study, for analysis of IPFP tissue samples at 2 and 20
weeks, a total of 21 skeletally mature (3–4 year old) female Suffolk-cross
sheep were allocated to 3 groups: a) 2 week ACL-R surgical group (N ¼
9), b) 20 week ACL-R surgical group (N¼ 7) and c) non-operated control
group (N¼ 5). These tissues were assessed by real time q-PCR for mRNA
levels of select molecules involved in remodelling and synthesis fol-
lowing surgery such as Collagen type I (Col-I), collagen Type III (Col-III)
and associated growth factors such as transforming growth factor beta
(TGF-b) and vascular endothelial growth factor (VEGF). The mRNA
expression levels were normalized to 18S mRNA. ANOVA with Bonfer-
roni post-hoc analysis was used to determined differences in expression
levels between groups, using SPSS 19.0.Results: Histological analysis of IPFP revealed a ﬁbrogenic reaction of
this tissue following ACL-R that was evident at 2 weeks post-injury.
Molecular analysis revealed that the mRNA levels for TGF-b were ele-
vated at 2 weeks following ACL-R surgery, but returned to levels close to
the un-operated controls by 20 weeks. The state of the tissue correlates
well with this molecular marker as it has been reported that TGF-b is a
potent inducer of processes observed in ﬁbrosis. VEGF is another
growth factor that plays a major role in angiogenesis and was found to
be elevated in the IPFP tissue in the early time points after ACL-R.
Interestingly, elevations in Type I and Type III collagen were also
observed in this fat pad, again consistent with a ﬁbrogenic process in
this tissue. The pattern of expression at the 2 and 20-week time points
were similar to that of the growth factors discussed above.
Conclusion: The present study suggests that anabolic factors are acti-
vated and expressed in the IPFP tissue in a similar pattern as observed
previously for synovium and cartilage in the same model. The initial
ﬁbrotic response did not resolve by 20 weeks post-injury, possibly
compromising the function of the IPFP in the long term.X – represents the moan expression level for each group and marker
shown
B, Δ - represent a single measure from each sample in the group
# - Signiﬁcant difference between Control and 2w expression levels
& - Signiﬁcant difference between 2 w and 20 weeks
@ - Signiﬁcant difference between Control and 20 weeks
Fig. 2. – H&E images of infrapatellar fat pad after ACL reconstruction 10
magniﬁcation
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DIFFERENT DISTRIBUTION AND ACTIVATION DEGREE OF TH17 CELLS
IN PERIPHERAL BLOOD IN PATIENTS WITH OSTEOARTHRITIS,
RHEUMATOID ARTHRITIS AND HEALTHY DONORS: PRELIMINARY
RESULTS OF THE MAGENTA CLICAO (CLINICAL CELL ANALYSIS IN
OSTEOARTHRITIS) STUDY
A. Lurati y, K. Re y, A. Gatti z, B. Brando z, M. Marrazza y, M. Scarpellini y.
yRheumatology Unit Fornaroli Hosp., Magenta, Italy; zHaematology Lab.
and Transfusion centre, Legnano, Italy
Background: Osteoarthritis (OA) as well as rheumatoid arthritis (RA) are
chronic diseases associated with joint destruction and mobility impair-
ment. Data about changes in immune system in RA and the signiﬁcant
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S296role of T cells, primarily Th17 cells, are nowwell recognised. On the other
hand data about immunological proﬁle in OA are limited, because OA has
long been regarded in the past as a no inﬂammatory disease. Our study
aim tomeasure thedistribution and the activationdegreeofCD4þ Th17 in
peripheral blood of OA, RA and age-matched healthy controls.
Methods: Patients with established diagnosis of RA according to ACR/
EULAR 2010 criteria, knee or hip OA according to ACR criteria and vol-
unteers healthy blood donors were eligible. Other inclusion criteria were
a DAS28 between 3.2 and 5.1 or a WOMAC Likert score more than 50,
respectively. Exclusion criteria were the presence of other autoimmune
diseases, tumours or secondary osteoarthritis. Finally no changes in
rheumatologic drugs were allowed from 3 months before enrolment.
Multichannel ﬂow cytometry was used for T cells subpopulation dis-
tinguishing and quantiﬁcation using monoclonal antibodies against CD3,
CD4, CD8, CCR6, CD38, CXCR3 and HLA DR. Participants were informed
about the aim of the project and gave their written consent. The project
was accepted by the Local Ethic Committee.
Results: We analysed blood samples of 91 subjects (75 females, 16
males). 15 Patients with well-deﬁned RA, 56 with hip or knee OA and 20
healthy controls. Mean age was 45  2.7 years old (p > 0.05 between
groups). Blood samples from the RA patients had signiﬁcantly higher
count of CD4þCD38þDRþ (activated CD4 T cells) and Th17
(CCR6þCXCR3-) cells as compared to OA patients and control group
(Figure) (P < 0.01). Furthermore the samples from the OA patients had
an higher percentage of activated CD4 T cells and Th17 cells as com-
pared to control group (P < 0.05)
Conclusion: According to the latest view of OA disease pathogenesis,
our preliminary results give support to the hypothesis that OA may also
(like RA) be a disease with an immunological/inﬂammatory involve-
ment. In fact it seems that there is a quantitative but non qualitative
difference in Th17 cells proﬁle, including the expression of activation
markers, between RA and OA.
517
PERIODONTITIS DISEASE AS A MODEL OF INFLAMMATION AND
BONE REMODELLING TO STUDY OSTEOARTHRITIS DRUG EFFECTS.
RESULTS FROM A PILOT STUDY IN OA PATIENTS TREATED WITH
CHONDROITIN SULFATE
A. Gurt y, C. Lopez y, M.J. Sales y, L. Tio z, P. Benito x, J. Monfort x. yCentro
de Atencion Primaria Vila Olímpica. PAMEM., Barcelona, Spain;
zGRICIC.FIMIM, Barcelona, Spain; xHosp. del Mar of Barcelona,
Barcelona, Spain
Purpose: Periodontitis is an inﬂammatory disease that affects 70% of the
adult population. Its most important consequence is the loss of bone
supporting the teeth. Its medical treatment so far has not shown to be
effective so only different surgical techniques are useful in advanced
stages. Osteoarthritis (OA) and periodontitis share physiopathological
characteristics. OA patients also suffer from an important inﬂammatory
component in the soft tissue and bone structural modiﬁcations. Because
of the evolution of the disease, development of new treatments is dif-
ﬁcult. Periodontitis could be a model for the study of OA, where thechanges of tissues could be observed in amore directlyway. Chondroitin
sulfate (CS) has shownapositive effect in different chronic inﬂammatory
diseases such as psoriasis, inﬂammatory bowel disease and OA. Perio-
dontitis is the most prevalent inﬂammatory disease, but currently
without speciﬁc treatment. New approaches for a safety and effective
pharmacological treatments are required. The purpose of this study was
to demonstrate that an effective drug inOApathologymay improve both
the inﬂammatory symptoms and the bone resorption occurred in
periodontal disease. This improvement would be reﬂected in changes in
biochemical markers of inﬂammation and bone metabolism.
Methods: Observational, prospective, pilot study in 26 patients diag-
nosed with knee OA and periodontitis. Patients were treated with CS
800 mg/day(Condrosan, Bioiberica SA) for 12 months. The L€oe and
Silness gingival index (used to assess soft tissue damage) and CPITN
(Community Periodontal Index of Treatment Needs) index were eval-
uated at 0, 3, 6, 9 and 12 months with saliva collection. Orthopanto-
mographys were performed at 0, 6 and 12 months to evaluate bone
damage. Vertical lesions were measured using a periodontal probe at 0,
6 and 12 months. Different concentration of inﬂammatory markers
(TNF -a, IL -1b, IL-18 and PGE2) and bonemetabolism (OPG, OPN, RANKL
and MMP-8) were quantiﬁed in the saliva by ELISA or protein array.
During the study, patients were asked to continue their usual oral
hygiene without additional treatments. Statistical analysis was per-
formed using Wilcoxon test for paired samples.
Results: L€oe and Silness index decreased signiﬁcantly after 6, 9 and 12
monthsof treatment (p¼0.004,0.007and0.002 respectively). In contrast,
no signiﬁcant changeswere observed in CPTIN values, probably due to the
fact that only the most affected tooth is studied and it can differ between
visits. Both orthopantomography as well as the vertical lesions evolution,
showed signiﬁcant improvement at 12 months (p ¼ 0.009) and 6 and 12
months respectively (p ¼ 0.002 and p ¼ 0.016). For biochemical analysis
results, patients with no gingival improvement were used as control
group.The results showabetterperformance in thegroupof responders to
treatment for inﬂammatory markers PGE-2, TNF-a and IL-1b , as well as
bone metabolismmarkers, OPN, MMP -8, and the ratio OPG/RANKL. Res-
ponders groups PGE2 levels showed a signiﬁcant decreased after 12
months of treatment (p¼ 0.033), whereas IL-1b levels in non responding
patients suffered a signiﬁcant increased after 3 and 6months of treatment
(p¼ 0.017)
Conclusions: CS improves soft tissue inﬂammation after 6 months of
treatment and bone support at 12 months in periodontal disease,
similar to the already known effect of the drug in OA disease. This
improvement is reﬂected in markers of inﬂammation and bone
metabolism in saliva. Due to its efﬁcacy and safety proﬁle, CS is
postulated as a good candidate for the treatment of this disease.Intervertebral disc
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ADIPOKINES AND THE INTERVERTEBRAL DISC: DOES A
BIOCHEMICAL LINK EXIST BETWEEN OBESITY AND BACK PAIN?
A. Segar y,z, K. Edwards x, J. Fairbank y, J. Urban x. yNufﬁeld Dept. of
Orthopaedics, Rheumatology and Musculoskeletal Sci., Univ. of Oxford,
OXFORD, United Kingdom; zDept. of Physiology, Anatomy and Genetics,
Univ. of Oxford, Oxford, United Kingdom; xDept. of Physiology, Anatomy
and Genetics, Univ. of Oxford, Oxford, United Kingdom
Purpose: Obesity is a signiﬁcant risk factor for development of low back
pain and intervertebral disc (IVD) degeneration. The mechanism
underlying this link is unclear but is commonly thought to arise from
altered loading. However, adipokines such as leptin and adiponectin,
produced by adipose tissue, are now known to be involved in degra-
dative processes particularly in articular joints. We propose a similar
link exists between these adipokines and intervertebral disc degener-
ation. Obese individuals are known to have higher concentrations of
serum adipokines, there is increased local fat in chronic spinal con-
ditions potentiating an increase in local adipokine levels and disc cells
are reported to have leptin receptors and can synthesise leptin.
The aim of the study was to identify responses of nucleus pulposus (NP)
and outer annulus ﬁbrosus (OA) cells to leptin and adiponectin. Once
identiﬁed, we proceeded to determine if synergistic effects exist in the
presence of other pro-inﬂammatory cytokines.
Methods: Bovine intervertebral discs were used as a model system.
Freshly isolated NP and OA cells embedded in 3D alginate beads, were
